|
Clinical Trial Confirms No Late Benefit for Routine Thrombus Aspiration in STEMI Patients
|
|
Medical Therapy with Ranolazine did not Reduce Adverse Events in Patients with Persistent Untreated Heart Artery Blockages after Percutaneous Coronary Intervention
|
|
First-in-Man Study Examines Angiographic and Clinical Outcomes of Newest Bioresorbable Magnesium Stent
|
|
Two-Year Data from the First Randomized Comparison Between Bioresorbable Vascular Scaffolds and Everolimus-Eluting Metallic Stents Show Comparable Patient Outcomes
|
|
Clinical Trial Demonstrates that a Bioresorbable Scaffold is Non-Inferior to a Drug-eluting Stent in Patients with Coronary Artery Disease
|
|
Clinical Trial Demonstrates that a Bioresorbable Scaffold is Non-Inferior to a Drug-Eluting Stent in Chinese Patients with Coronary Artery Disease
|
|
Accessing the Heart Via the Arm During Ad-hoc PCI Has Similar Ischemic Outcomes Compared to Conventional Groin Access at One Year with Potential for Lower Bleeding
|
|
Data Presented at TCT 2015 will Demonstrate Whether the "Disappearing Stent" is a Major Breakthrough in Angioplasty
|
|
CRF Announces Press Conference Schedule for TCT 2015
|
|
Jason Ware Joins CRF as Director, Meeting Planning
|
